From making the world a better place, to offering attractive returns, the biotech sector is rapidly becoming an attractive investment asset class
So, it’s no surprise that the sector is experiencing a global surge in investors.
Billions upon billions have been recently invested, and, as more money floods into the biotech sector, it means more breakthrough discoveries, which in turn, saves lives.
“The biotech sector is an identified asset class in the U.S., but outside of it, it really hasn’t really caught on as much,” Cure Brain Cancer Foundation CEO Lance Kawaguchi recently revealed.
“I’m trying to also educate people that early stage Phase 0, Phase 1 and even Phase 2 biotechs are also attractive asset classes.”
One organisation that understands the importance of investment in research is Alma Life Sciences, as they are an early-stage investment firm focusing on the creation and growth of innovative healthcare companies.
“Investment is important in early stages, not just Phase 3, but mainly in early stages,” Alma Life Sciences co-founder Dr. Magda Marquet asserts.
“We have to realise that as a society, we live longer and, and because of this, we have the possibility to have cancers at later stages of our lives.
“So, we need to constantly bring new approaches and new solutions.”
Marquet uses the example of how investing in Oncology has been rewarding, both on a philosophical and financial level.
“Investing in Oncology has played a major role in decreasing the global death rate,” she continues. “As biotech becomes the pipeline for Pharma, research can be invested in at early stages, which is not the case in other diseases.
“It’s a very important area of investment.
“And the fact that you make not just financial (rewards), you can have the opportunity of a huge financial gain, but you also have a huge impact in society.”
Just as the rewards can be life-changing, the risks involved – both at a research and investment level – are also high, and can take many years for the fruits of the labour to come to fruition.
“The risks that people hear comes from a lack of understanding – the fact that it takes a long time,” Marquet continues to elaborate.
“In another sector, the path is a lot more clear.
“In biotech, the risk-reward equation, it’s a little different. So that’s why I think education is so important.”
Former President Donald Trump and current President Joe Biden have agreed to participate in two debates in June and September.
On this episode of Ticker Hot Shots – Former President Donald Trump and current President Joe Biden agree to a double debate, Trump backs AUKUS, MacDonalds creates a price friendly meal and Prince Harry faces the financial music. #featured #trending #hotshots
Amidst the dominance of cloud technologies in the tech landscape, questions are rising over applicability and its cost implications.
As businesses increasingly migrate to cloud technologies, skepticism is brewing over whether it’s the optimal solution for every organisational need.
Additionally, the notion of “free” cloud services is being challenged, highlighting the importance of understanding the true costs and benefits associated with cloud adoption.
Harsha Patil, Engineering manager, California USA shares his key insights on the cloud conundrum. #featured
Intermittent fasting involves cycling between periods of eating and fasting, and time-restricted feeding, where eating is restricted to certain hours of the day.
Intermittent fasting has proved to be more sustainable for some participants, leading to better adherence and overall success in shedding excess weight.
Kate Save from BeFitFood joins to discuss the potential benefits of intermittent fasting. #featured #trending